Searched for
ALOPECIA AREATA
Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...
Sun Pharma shares in focus after $200 million settlement in US drug pricing caseShares of Sun Pharma will be in focus after the company said its subsidiaries, SPII and Taro, have agreed to pay $200 million to settle an ...
Sun Pharma’s baldness drug Leqselvi debuts in US market after patent dispute settledSun Pharmaceutical Industries has reached a settlement agreement with Incyte Corporation concerning Leqselvi, a drug for severe hair loss, ...
Sun Pharma shares in focus following US launch of LEQSELVITM, settlement with Incyte CorporationSun Pharma shares: In a regulatory filing on Monday, Sun Pharma announced that it has reached a settlement and licensing agreement with Inc...
Sun Pharma gets US FDA nod for its specialty drug against baldnessSun Pharma announced FDA approval of Leqselvi (deuruxolitinib) 8 mg tablets for severe alopecia areata, marking a major milestone after acq...
Sun Pharma's drug to treat alopecia areata gets USFDA nodSun Pharmaceutical Industries Ltd announced that the USFDA has approved its drug LEQSELVI (deuruxolitinib) for treating adults with severe ...
Sun Pharma subsidiary partners with Aclaris Therapeutics for licensing agreementAs per the pact, Aclaris grants Sun Pharma exclusive rights to specific patents for using deuruxolitinib, Sun Pharma's JAK inhibitor, or ot...
A commonly used arthritis medicine can cure baldness, shows a studyA recent study published in Indian Dermatology has found that tofacitinib, a drug commonly used for rheumatoid arthritis, has shown promisi...
Sun Pharma files new drug application with USFDA for investigational medicine to treat alopeciaThe new drug application filing for deuruxolitinib with the USFDA is based on two pivotal Phase III trials, which included over 1,200 patie...
Sun Pharma completes acquisition of Concert PharmaceuticalsThe drug major has successfully completed the acquisition of Concert Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company ...
Sun Pharma to buy concert for $576 mConcert has pioneered the use of deuterium (a hydrogen isotope) in medicinal chemistry and has an extensive patent portfolio, including its...
Sun Pharma to acquire US-based Concert for $576 millionConcert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patc...
Sun Pharma to acquire US-based Concert for $576 millionConcert's lead candidate, deuruxolitinib, is being evaluated as a treatment for autoimmune condition alopecia areata, which results in patc...
Jada Pinkett Smith signs deal for tell-all memoir with HarperCollins PublishersFrom her complicated friendship with late rapper Tupac Shakur to dealing with hair loss, this memoir will bare all.
First drug to treat hair loss disorder alopecia gets FDA approvalU.S. FDA has approved Eli Lilly's drug, Olumiant, which is considered the first to treat severe hair loss.
Will Smith vs Chris Rock Oscar slapgate: Jada Pinkett Smith hopes the 'two intelligent, capable men reconcile'She and husband Will Smith, a best-actor nominee, were in the audience as presenter Chris Rock cracked a joke at Pinkett Smith's expense.
Alopecia Areata: What you need to knowAlopecia Areata is an autoimmune disorder that leads to loss of hair in clumps or patches.
From Covid to alopecia, the pain of going bald is real: Hair loss can be depressing & affect people's sense of selfJade Pinkett Smith spoke out for the first time in 2018 about her alopecia diagnosis.
Chris Rock joked about Will Smith wife's baldness at Oscars 2022. But alopecia is an autoimmune disorder & needs attentionJada Pinkett Smith revealed in 2018 that she had been struggling with alopecia.
New drugs that may cure baldness foundThe drugs inhibit a family of enzymes inside hair follicles that are suspended in a resting state, restoring hair growth.